Beta-Glucan (Oat / Barley)
(1,3/1,4)-β-D-glucan
The viscous oat/barley soluble fiber with FDA- and EFSA-backed proof it lowers LDL cholesterol and blunts post-meal glucose.
Evidence tier
Strong
Research weight
Citations
9 verified / 9
Classification
Prebiotics & Fibers
❝
What the evidence says. Multiple high-quality RCTs / meta-analyses with consistent effects.
What is Beta-Glucan (Oat / Barley)?
Beta-Glucan (Oat / Barley) ((1,3/1,4)-β-D-glucan) is a prebiotic fiber used for lowers ldl ('bad') and total cholesterol: ~3 g/day reduces ldl by roughly 0.2-0.3 mmol/l (about 5-7%) in randomized trials, the basis of fda and efsa heart-health claims. NutriDex grades the human evidence as Strong. Beta-glucan is a soluble, viscous, mixed-linkage (1,3/1,4)-beta-D-glucan fiber concentrated in oats and barley (and the active fiber behind oatmeal's heart-health reputation). Its evidence for lowering LDL and total cholesterol is among the strongest of any dietary fiber: dozens of randomized trials and multiple meta-analyses show roughly 3 g/day cuts LDL cholesterol by about 0.2-0.3 mmol/L, which underpins both an FDA-authorized and an EFSA-approved heart-health claim. It also reliably blunts post-meal blood glucose and insulin when eaten with carbohydrate (another EFSA-authorized claim), with smaller and less consistent effects on long-term HbA1c. Evidence for satiety/modest weight effects is moderate, and while beta-glucan is fermented to short-chain fatty acids (notably propionate) and shifts the microbiota, it is not a classic bifidogenic prebiotic and the human gut-flora data are thinner than the cholesterol data.
Purported Benefits
✓Lowers LDL ('bad') and total cholesterol: ~3 g/day reduces LDL by roughly 0.2-0.3 mmol/L (about 5-7%) in randomized trials, the basis of FDA and EFSA heart-health claims
✓Blunts post-meal (postprandial) glucose and insulin spikes when eaten with carbohydrate by forming a viscous gel that slows gastric emptying and carbohydrate absorption (EFSA-authorized glycemic claim)
✓Modestly improves long-term glycemic markers (small HbA1c and fasting-glucose reductions) in some trials, with larger cholesterol benefit seen in people with diabetes and higher baseline LDL
✓Is fermented by gut bacteria to short-chain fatty acids (a propionate-rich profile) and shifts microbiota composition, though it is not a strongly bifidogenic 'classic' prebiotic
✓Increases satiety and can produce small reductions in body weight, BMI, and energy intake via gut-hormone (higher PYY, lower ghrelin) and viscosity effects
✓Adds to total soluble fiber intake supporting normal bowel function and stool regularity
Evidence by outcome
The same supplement can be well-proven for one use and unproven for another — here is the human evidence graded outcome by outcome.
| Outcome | Evidence | Effect | Studies |
|---|---|---|---|
| Lowers LDL & total cholesterolDozens of RCTs and multiple meta-analyses: ~3 g/day cuts LDL ~0.2-0.3 mmol/L; basis of FDA & EFSA claims. | Strong | ↑ benefit · moderate | 3 |
| Blunts postprandial glucose & insulinReliable viscosity-driven effect when eaten with carbohydrate; EFSA-authorized glycemic claim. | Strong | ↑ benefit · moderate | 2 |
| Improves long-term glycemia (HbA1c, fasting glucose)Meta-analysis shows small HbA1c/fasting-glucose reductions; smaller and less consistent than the cholesterol effect. | Moderate | ↑ benefit · small | 1 |
| Modest body-weight / BMI reductionMeta-analysis found small weight/BMI drop, but >4 g/day linked to higher energy intake; modest. | Preliminary | ↑ benefit · small | 1 |
| Bifidogenic prebiotic effectFermented to propionate-rich SCFA but in-vitro data show no strong classic bifidogenic effect; human gut data thin. | Preliminary | ↔ mixed · small | 1 |
Dosing & Compounds
Typical Dose
At least 3 g/day of beta-glucan for cholesterol lowering (the FDA and EFSA threshold), typically from ~3 servings of oats/oat bran or a beta-glucan-enriched food/supplement; trials used a median of ~3.5 g/day. For blunting post-meal glucose, EFSA specifies at least 4 g of beta-glucan per 30 g of available carbohydrate eaten in the same meal (a 2025 EFSA opinion supports a lower oat threshold of 3 g per 30 g carbohydrate). Best taken with meals and with adequate fluid; benefits depend on the fiber's molecular weight and viscosity being preserved (heavy processing can reduce efficacy.)
Active Compounds
Safety & Cautions
Generally very well tolerated and safe as a food. Because it is fermentable, the main side effects are gas, bloating, and abdominal fullness, which are usually mild and lessen if the dose is increased gradually; people with IBS or sensitivity to fermentable carbohydrates may notice more gas. Take with adequate fluid. As a viscous soluble fiber, beta-glucan can slow gastric emptying and may delay or reduce the absorption of co-ingested medications, so separate it from time-sensitive drugs (e.g., thyroid hormone, certain antibiotics) by a couple of hours. People with diabetes on glucose-lowering medication should monitor blood sugar, since beta-glucan can enhance glucose-lowering and add to that effect. Those with celiac disease should use certified gluten-free oats (oats are often cross-contaminated, and barley contains gluten). Anyone with swallowing difficulty, esophageal narrowing, or a suspected bowel obstruction should avoid concentrated fiber supplements taken with little water. Beta-glucan does not carry the choking/esophageal-obstruction hazard associated with glucomannan/konjac, but any concentrated fiber should be taken with plenty of liquid. Educational only — always check with your doctor or pharmacist before combining Beta-Glucan (Oat / Barley) with any medicine.
Key Studies
Systematic review and meta-analysis of RCTs
Shen 2022 (13 RCTs)
✓ Full text
In hypercholesterolemic adults, oat beta-glucan significantly reduced LDL cholesterol (pooled WMD -0.27 mmol/L; 95% CI -0.35 to -0.20) and total cholesterol versus control across 13 randomized trials.
Meta-analysis of RCTs
Zhu 2020 (cereal beta-glucan, weight)
✓ PubMed
A meta-analysis of randomized controlled trials found cereal beta-glucan consumption modestly reduced body weight and BMI, while doses above ~4 g/day were associated with higher total energy intake.
Systematic review and meta-analysis of RCTs
Ho 2016 (58 RCTs, n=3,974)
✓ PubMed
A systematic review and meta-analysis of 58 trials found a median 3.5 g/day of oat beta-glucan significantly lowered LDL-cholesterol by 0.19 mmol/L, non-HDL-cholesterol by 0.20 mmol/L, and apoB by 0.03 g/L versus control.
Systematic review and meta-analysis of RCTs
He 2016 (glycemic, RCTs)
✓ PubMed
A systematic review and meta-analysis of RCTs in hypercholesterolemic individuals found beta-glucan consumption (~2.5-3.5 g/day) significantly lowered fasting glucose and HbA1c, with greater cholesterol benefit in people with diabetes.
Regulatory scientific opinion
EFSA Panel 2025 (oat beta-glucan glycaemia)
✓ Source
A 2025 EFSA opinion supported modifying the post-prandial glucose claim for oat beta-glucan to a lower threshold of 3 g per 30 g of available carbohydrate per meal.
Meta-analysis of RCTs
Whitehead 2014 (28 RCTs)
✓ Full text
A meta-analysis of 28 randomized controlled trials found oat beta-glucan at >=3 g/day reduced LDL cholesterol by 0.25 mmol/L (95% CI 0.20-0.30) and total cholesterol by 0.30 mmol/L vs control, with no effect on HDL or triglycerides.
Regulatory scientific opinion
EFSA Panel 2011 (ID 1236/1299, 821/824)
✓ Source
EFSA concluded a cause-and-effect relationship between beta-glucans from oats and barley and maintenance of normal blood LDL-cholesterol, and reduction of post-prandial glycaemic responses, supporting authorized EU health claims.
Regulatory authorization
FDA 21 CFR 101.81
✓ Source
The FDA authorizes a coronary-heart-disease health claim for foods supplying >=3 g/day of beta-glucan soluble fiber from whole oats or barley, requiring at least 0.75 g per serving.
In vitro fermentation study
Hughes 2008 (in vitro fermentation)
✓ PubMed
Human faecal fermentation of oat and barley beta-glucans produced a propionate-rich short-chain fatty acid profile (acetate:propionate:butyrate ~51:32:17) and modulated microbiota, though without a strong classic bifidogenic effect.